These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6998997)

  • 21. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.
    Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
    Bäckström M; Hall K; Sara V
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatomedin levels in childhood, adolescence and adult life.
    Hall K; Sara VR
    Clin Endocrinol Metab; 1984 Mar; 13(1):91-112. PubMed ID: 6327127
    [No Abstract]   [Full Text] [Related]  

  • 24. Somatomedin-C and the assessment of growth.
    Underwood LE; D'Ercole AJ; Van Wyk JJ
    Pediatr Clin North Am; 1980 Nov; 27(4):771-82. PubMed ID: 7005847
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
    Kemp SF; Rosenfeld RG; Liu F; Gaspich S; Hintz RL
    J Clin Endocrinol Metab; 1981 Apr; 52(4):616-21. PubMed ID: 7204536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatomedin A in human serum, determined by radioreceptor assay.
    Takano K; Hall K; Ritzén M; Iselius L; Sievertsson H
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):449-59. PubMed ID: 947120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal and polyclonal antibodies compared for radioimmunoassay of somatomedin-C in patients with acromegaly or hypopituitarism.
    Burrin JM; Paterson JL; Sharp PS; Yeo TH
    Clin Chem; 1987 Sep; 33(9):1593-6. PubMed ID: 3621559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors.
    Mesiano S; Young IR; Browne CA; Thorburn GD
    J Endocrinol; 1988 Dec; 119(3):453-60. PubMed ID: 2464662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current views on somatomedin (sulfation factor)].
    Cianfriglia F
    Folia Endocrinol; 1973 Feb; 26(1):71-84. PubMed ID: 4739853
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum levels of receptor assayable insulin-like activity in various diseases].
    Namba O; Hyodo T
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1714-28. PubMed ID: 6365608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive somatomedin B in acromegaly and in Turner's syndrome.
    Benker G; Spira G; Zäh W; Tharandt L; Hackenberg K; Reinwein D
    Clin Endocrinol (Oxf); 1979 Oct; 11(4):357-65. PubMed ID: 519875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A screening method for measuring somatomedin B protein binding in serum from children with growth retardation.
    Rudd BT; Rayner PH; Stafford SM; Halliday R
    Ann Clin Biochem; 1982 Mar; 19(Pt 2):83-8. PubMed ID: 6176174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease.
    Takano K; Hizuka N; Shizume K; Hayashi N; Motoike Y; Obata H
    J Clin Endocrinol Metab; 1977 Oct; 45(4):828-32. PubMed ID: 914986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain growth-promoting activity in human serum: relationship to growth hormone and somatomedin.
    Sara VR; Stuart MC; Rutherford R; Moore S; Lazarus L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1129-31. PubMed ID: 263343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.
    Hintz RL; Liu F
    J Clin Endocrinol Metab; 1982 Feb; 54(2):442-6. PubMed ID: 6172444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration.
    Daughaday WH; Ward AP; Goldberg AC; Trivedi B; Kapadia M
    J Clin Endocrinol Metab; 1982 Nov; 55(5):916-21. PubMed ID: 6749881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of insulin and somatomedin A to human placental membrane.
    Takano K; Hall K; Fryklund L; Holmgren A; Sievertsson H; Uthne K
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):14-31. PubMed ID: 1173978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum somatomedin A in chronic renal failure.
    Takano K; Hall K; Kastrup KW; Hizuka N; Shizume K; Kawai K; Akimoto M; Takuma T; Sugino N
    J Clin Endocrinol Metab; 1979 Mar; 48(3):371-6. PubMed ID: 218989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.